A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy
Clinical trial NCT04148430 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04148430
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-30
- Primary completion
- 2026-10-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.